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ABSTRACT 
The aim of this research work was to design develop & evaluate oral fast disintegrating tablets of Ranitidine HCL. The Orodispersible tablets of 
Ranitidine HCl were prepared by using direct Compression technique with a Synthetic Superdisintegrant such as Crosspovidone and a natural 
Superdisintegrant Fenugreek gum in different concentration. 32 factorial designs was applied to study the effect of independent variables,  
concentration of Crosspovidone & Fenugreek gum on dependent variables like Cumulative % Drug release and Disintegration time by using 
design expert software. Prepared oral fast disintegrating tablets evaluated for Pre and Post-compression parameters. The prepared tablets 
exhibited satisfactory physico-chemical characterise especially fast disintegration & dissolution property. Full factorial design and optimization 
technique successfully used in the development oral fast disintegrating tablets. Comparing the all the formulations, formulation F9 was 
considered as optimized formulation which shows excellent fast disintegration, in vitro dissolution, and faster drug release within 6 min in 
comparison to other batches also stable in stability study.  
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INTRODUCTION 
Tablet is the most popular among all dosage forms existing 
today because of its convenience of self administration, 
compactness and easy manufacturing. The difficulty is 
experienced in particular conventional tablet dosage form by 
pediatric and geriatric patients, bedridden patient and to 
those active working patients who are busy or traveling, 
especially those who have no access to water1.      
For the past three decades, there has been an enhanced 
demand for more patient compliant dosage form. As a result, 
the demand for their technologies increasing two to three 
folds annually1. 
Recent developments in technologies have come out with 
mouth dissolving tablets that can be ingested simply by 
placing them on the tongue. An orally fast disintegrating 
tablet is a solid dosage form that dissolves or disintegrates 
within a minute in the oral cavity without the need of water 
and has a pleasant taste3,4.  
Orally  fast disintegrating tablets is also known as orally 
mouth dissolving tablet, fast-dissolving tablet, fast-melting 
tablet, mouth melting tablet or fast-disintegrating tablet. Fast 
disintegrating dosage form has been successfully 
commercialized and the growing importance was 
highlighted recently when the European Pharmacopoeia 
adapted the term ‘Orodispersible Tablets’ as a tablet to be 
placed in the mouth where it disperses rapidly before 
swallowing4. United States Food and Drug Administration 
(FDA) defined ODT as “A solid dosage form containing 
medicinal substance or active ingredient which disintegrates 
rapidly usually within a matter of seconds when placed upon 
the tongue.” The disintegration time for ODTs generally 
ranges from several seconds to about a minute5,6,7.  
USFDA defined OD tablet as “A solid dosage form containing 
medicinal substances, which disintegrates rapidly, usually 
within a matter of seconds, when placed upon the tongue”. 
Recently European Pharmacopoeia also adopted the term 
“Oro Dispersible tablet” as a tablet that is to be placed in the 
mouth where it disperses rapidly before swallowing. These 
dosage forms dissolve or disintegrate in the patient’s mouth 
within 15 seconds to 3 minutes without the need of water or 
chewing. Despite various terminologies used, Oro-
Dispersible tablets are here to offer unique form of drug 
delivery with many advantages over the conventional oral 
solid dosage forms.8,9,10     . 
Ranitidine HCL is a used for the maintenance treatment of 
acidity. It is usually administered orally. With oral 
administration, the mean half-life of Ranitidine HCL is 2.7-5.5 
hours. It is rapidly absorbed following oral administration 
(bioavailability is 64%), metabolize in liver, and its 
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metabolites are excreted by urine. The drug undergoes 
hepatic metabolism, so the attempt has been made to 
administer it as mouth dissolving tablet to increase its oral 
bioavailability. Oral fast Disintegrating tablets  are the oral 
solid dosage forms which when placed on tongue, 
disintegrates rapidly, releasing the drug, which dissolves or 
disperses in the saliva and swallowed without the need of 
drinking water. Thus, they are beneficial to patients who find 
it difficult to swallow tablets particularly the geriatric and 
pediatric patients. Hence, an attempt was made to develop 
and evaluates FDT of Ranitidine HCL using direct 
Compression technique11,12,13,.  
MATERIALS AND METHODS 
Ranitidine HCl was gift sample from Gift sample from J.B. 
Chemicals. Ltd. Anklaeshwar, Fenugreek gum powder was 
purchased from Agro food industry Ahemadabad, 
Crosspovidone, Aspartame Mg. stearate,Talc and Lactose 
were purchased from Research Lab Fine Chem. Ltd. Mumbai  
I) Drug-Excipients Compatibility Studies: 
FTIR STUDIES: 
IR spectra for pure drug Ranitidine HCl and Combination of 
drug with Superdisintegrants were recordedin a Fourier 
transform infrared (FTIR) spectrophotometer (Perkin 
ElmerInstruments, USA) with KBr pellets. 
II) Method of preparation of Oral Fast Disintegrating 
Tablets:  
Tablets of Ranitidine HCl were prepared by Direct 
Compression method. Specified quantity of drug, Fenugreek 
gum,crosspovidone,Aspartame, Talc,Magnesium stearate, 
Lactose were weighed accurately and passed through 60# 
screen prior to mixing. All the excipients without Magnesium 
stearate were mixed uniformly followed by addition of 
magnesium stearate.All the materials were transferred to 
mortar and triturated till it mixed uniformly and compressed 
into single punch tablet machine of 9 mm sizes flat round 
punch to get tablet using Rimek Compression Machine 
Karnavati Minipress II model. 
Factorial Design 
In the present research work 32 factorial designs was applied 
to study the effect of independent variables, i.e. 
concentration of crosspovidone & Fenugreek gum on 
dependent variables like Cumulative % Drug release and 
Disintegration time   by using design expert software. 
Table 1:  Layout of coating material by 32 full factorial 
designs 
Batch no X1 X2 
F1 -1 -1 
F2 +0 -1 
F3 +1 -1 
F4 -1 0 
F5 0 0 
F6 +1 0 
F7 -1 +1 
F8 0 +1 
F9 +1 +1 
 
Table 2: Value codes of factorial design 
Coded 
value 
Crosspovidone(mg) 
(X1) 
Fenugreek gum(mg) 
(X2) 
-1 10 12 
0 13                     15 
+1 16 18 
 
  
Table 3: Formulation of 32Factorial Design Batches 
Formulation 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
Ingredients(mg) 
Ranitidine HCl 150 150 150 150 150 150 150 150 150 
Crosspovidone 10 13 16 10 13 16 10 13 16 
Fenugreek gum 12 12 12 15 15 15 18 18 18 
Aspartame 10 10 10 10 10 10 10 10 10 
Talc 5 5 5 5 5 5 5 5 5 
Magnesium stearate 5 5 5 5 5 5 5 5 5 
Lactose 58 55 52 55 52 49 52 49 46 
Total wt. of Tablet 250 250 250 250 250 250 250 250 250 
 
III) Evaluation of Oral Fast Disintegrating Tablets: 
14,19,20,21,22,23,24 
a) General Appearance and Physical Properties 
i) Color, Odor 
The general appearance of a tablet, its visual identity and 
over all "elegance" is essential for consumer acceptance.  
b)Uniformity of thickness5,6 
Thickness of tablets was important for uniformity of tablet 
size. Thickness was measured using screw gauze on 
randomly selected samples. 
c) Hardness/crushing/tensile strength: 
The tablet tensile strength is the force required to break a 
tablet by compressing it in the radial direction and is 
measured using a tablet hardness tester. For measuring the 
hardness of the tablets, the plunger of the hardness tester is 
driven down at a speed of 20 mm/min. Tensile strength for 
Crushing (T) is calculated using equation: 
= 2F / πdt 
d) Friability test: 
It is the phenomenon where by tablet surfaces are damaged 
and show evidence of lamination or breakage when 
subjected to mechanical shock of attrition. The friability of 
tablets was determined by using Roche Friabilator. It is 
expressed in percentage (%). Twenty tablets were initially 
weighed (Winitial) and transferred into Friabilator. The 
Friabilator was operated at 25 rpm for 4 minute surround up 
to100 revolutions. The tablets were weighed again 
(Wfinal).The percentage friability was then calculated by, 
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% Friability of tablets less than 1%is considered acceptable. 
e) Uniformity of Weight: 
I.P. procedure for uniformity of weight was followed, twenty 
tablets were taken and their weight was determined 
individually and collectively on a electronic weighing 
balance. The average weight of one tablet was determined 
from the collective weight. The weight variation test would 
be a satisfactory method of determining the drug content 
uniformity. 
f) In-vitro disintegration time 
The process of breakdown of a tablet into smaller particles is 
called as disintegration. The in-vitro disintegration time of a 
tablet was determined using disintegration test apparatus as 
per I.P. specifications. 
g)  Wetting time: 
The following method for calculating the wetting time of the 
tablet. A piece of filter paper (circularly cut) was placed in a 
small Petri- plate containing water soluble dye solution. 
Tablet was placed on the paper and the time required for 
complete wetting of the tablet was determined used a tissue 
paper folded twice and was placed in a small culture dish (id 
= 6.5 cm) containing 6 ml of water. 
h) Water absorption ratio:  
Similar to the procedure followed in determination of 
wetting time. However, here the initial weight and the final 
weight (after complete wetting) of tablet were calculated and 
the water absorption ratio was calculated by given formula: 
 
Where, R is water absorption ratio, Wa and Wb are the 
weights of tablet before and after wetting respectively. 
 i) Drug content uniformity: 
Ten tablets were powdered and blend equivalent to 150 mg 
of Ranitidine hydrochloride was weighed and dissolved in 
suitable quantity of phosphate buffer pH 6.8. The solution 
was filtered through 0.45 mm membrane filter and the 
amount of Ranitidine was estimated by using standard 
calibration curve of the drug. UV absorbance was measured 
at 315 nm. 
j) In-vitro dissolution studies: 
The release of drug from different batches of prepared tablets 
was studied by using USP dissolution apparatus type II. The 
dissolution medium consisted of 900ml of 6.8 phosphate 
buffer, speed of 50rpm & the temperature was maintained at 
37°C ± 0.5°C. Samples of 1ml were withdrawn at through a 
filter of 0.45 mm at regular time intervals and the same 
volume was replaced with fresh dissolution medium. The 
samples were measured by UV Spectrophotometer at 315nm 
for sustained release layer against a blank. 
k) Stability Studies: 
The stability study of optimized formulation was carried out 
as per ICH guidelines at40 ºC ± 2ºCand 75% RH using 
stability chamber for three months.  
RESULT AND DISCUSSION 
Drug polymers compatibility studies 
The IR spectrum of pure drug was found to be similar to 
their reference standard IR spectrum of Ranitidine HCL 
given in pharmacopoeia. 
 
Figure 1: FTIR Spectrum of Pure drug (Ranitidine HCL) 
 
Figure 2: FTIR spectrum of Drug in Formulation blend 
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From FTIR study it can concluded that the drug Ranitidine 
HCL have maintained its identity without losing its 
characteristic properties in formulation blend. 
Evaluation parameter of Oral fast disintegrating Tablets: 
a)  General Appearance and Physical Parameter: 
Color: off White 
Odor: odorless 
b) Thickness: The thickness of all formulations was found to 
be in the range between 3.96±0.24 to 4.03±0.06 mm.  
c)  Hardness: The hardness of all the entire formulations was 
found to be in the range between 3.10±0.09 to 3.56±0.22 
kg/cm2. 
d) Percentage Friability: The Friability of all formulations 
was found to be in the range between 0.21±0.02 to 
0.27±1.06%. 
e) Uniformity of weight: The Weight variation of all 
formulations was found to be in the range between 
246.64±0.9to 249.21±1.24 mg. 
f) Disintegration time: The Disintegration time all batches 
were found between the ranges 22-34seconds. 
  
Table 4: Evaluation parameter for FDT of Ranitidine HCL 
Formulations 
Thickness 
mm 
±SD, n=3 
Hardness 
Kg/cm2 
± SD, n=3 
Friability % 
± SD, n=3 
Average wt. 
(mg) 
±SD, n=3 
Disintegration 
time sec. 
 ±SD, n=3 
F1 3.96±0.24 3.21±0.22 0.21±0.02 249.21±1.24 29±0.7 
F2 4.01±0.02 3.10±0.09 0.22±0.14 247.94±1.02 28±0.4 
F3 4.02±0.09 3.28±0.64 0.24±1.04 246.64±0.9 28±0.8 
F4 4.00±0.75 3.25±0.39 0.25±0.27 248.32±1.41 31±0.7 
F5 4.01±0.66 3.11±0.22 0.22±0.26 247.96±1.23 33±0.8 
F6 4.00±0.76 3.13±0.12 0.27±1.06 249.02±0.32 34±0.2 
F7 3.98±0.84 3.31±0.19 0.25±0.46 248.66±1.41 27±0.5 
F8 4.03±0.06 3.56±0.22 0.23±0.27 247.06±0.23 25±0.9 
F9 4.00±0.16 3.12±0.02 0.27±0.18 248.98±0.64 22±0.2 
± SD= Standard deviation 
Table 5: Wetting time, Water absorption ratio, % Drug content 
Batches 
Wetting time (Sec) 
± SD, n=3 
Water absorption ratio 
± SD, n=3 
% Drug content 
± SD, n=3 
F1 26±0.56 60±0.60 99.10±1.08 
F2 23±1.20 52±1.63 98.44±1.22 
F3 28±0.06 66±0.38 97.98±1.16 
F4 22±1.40 67±1.04 96.90±1.44 
F5 24±1.08 62±1.16 95.46±1.21 
F6 25±0.41 56±0.72 98.14±1.28 
F7 22±1.14 61±0.44 97.80±1.44 
F8 23±1.28 68±1.06 98.46±1.20 
F9 19±0.82 68±0.72 99.20±1.08 
 
g) Wetting time:  Wetting time of all formulations was found to be in the range between 19±0.82 to 26±0.56. 
h) Water absorption ratio: Water absorption ratio of all formulations was found to be in the range between 52±1.63 to 
68±1.06. 
i) Drug content:  Drug content of all formulations was found to be in the range between 97.98±1.16 to 99.20±1.08. 
j)  In vitro dissolution profile of formulation batches 
 
Figure 3: In-vitro drug dissolution studies of Formulations F1 to F9 
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All the nine formulations were subjected for the in vitro 
dissolution studies using tablet dissolution tester. The 
sample were withdrawn at different time intervals and 
analyzed at 315 nm. Cumulative drug release was calculated 
on the basis of mean amount of Ranitidine HCl present in 
respective tablet. The results obtained in the in vitro drug 
release for the formulations F1, F2, F3, F4, F5, F6, F7, F8, F9 
are tabulated in Table 6.8 the dissolution rate was found to 
increase linearly with increasing Concentration of 
superdisintegrants. 
From the outcome of above results, it was clear that the 
formulation F9 was the best formulation having comparable 
disintegration time and in vitro drug release.  
The drug release of the best F9 formulation was found to be 
99.56% with in 6 minute.   The tablet prepared using 
Crosspovidone and fenugreek powder (F9) were found to be 
best formulations that showed the dissolution rate in 6 
minutes. 
Optimization study outcome: 
The targeted response parameter were statistically analyzed 
by applying one way ANOVA at significant level and the 
significance of the model was calculated by Design & Expert 
software. The individual parameter evaluated by using F test 
and mathematical relationship was generated between the 
factor dependent variables and independent variables for 
determining the level of factor which give optimum 
Disintegration time and drug release. 
The response surface diagram gives knowledge to 
understand contribution of the variables and their 
interaction. The response curve map is shown for all 
response in figure. 
Figure 4 & 5 shows both variables have effect on the 
Disintegration time (R1) and Cumulative % drug release 
(R2). The model F-value for disintegration time was found to 
be 37.92 and for Cumulative % drug release 11.90 which 
imply model is significant. The result of ANOVA study shows 
model is significant. 
Final Equation for D.T. in Terms of Coded Factors: 
                                                                                              DT                                                    =
 +33.03 
 
-1.33 * A 
-3.17 * B 
+0.25 *AB 
-0.62 * A2 
-9.12 * B2 
 
Final Equation in Terms of Coded Factors: 
DR in 5 minutes = 
+76.91 
 
+4.11 * A 
+7.73 * B 
+3.09 * AB 
+0.58 * A2 
+5.64 * B2 
 
Table 6: The result of ANOVA 
Response model 
Sum of 
square 
Degree of 
freedom 
Mean 
square 
F 
value 
P value 
R 
square 
Ade. 
Precision 
Disintegration Time 283.94 2 141.97 37.92 0.0002 0.9312 11.185 
Cumulative % drug 
release in 5 Minutes 
11.95 2 55.97 11.90 0.0056 0.9488 16.75 
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Figure 4: A response surface plot showing effect of concentration of independent variables on the Disintegration time 
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Figure 5: A counter plot showing relationship between various levels of independent variables to gain fixed value of 
Disintegration time 
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Figure 6: A response surface plot showing effect of concentration of independent variables on the % Drug release 
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Figure 7: A counter plot showing relationship between various levels of independent variables to gain fixed value of% 
Drug release 
Full factorial design and optimization technique successfully used in the development oral fast disintegrating. 
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  k) Stability study 
Table 7: Stability study of optimized batch F9  
Condition 
Time 
(months) 
Wetting time 
(sec) 
± SD, n=3 
Friability 
(%) 
Disintegration 
time (sec) 
±SD, n=3 
% Drug 
release 
Accelerated 
temperature 400C and 
75% RH 
3 19±0.72 0.20±0.12 22±0.2 99.39 
 
 
 
Figure 8: In-vitro drug dissolution Stability study of f9 
optimized Formulation 
 F9= Before stability study 
 F9= After stability study 
Stability Studies are done according to the ICH Guidelines to 
assure that the product retains its full activity up to the end 
of its shelf-life at 40ºC± 2°C at 75% RH during 3 months. The 
results were found to be satisfactory with no significant 
variable changes. 
CONCLUSION 
 Oral fast Disintegrating tablet of Ranitidine HCl were 
prepared by using direct Compression technique with a 
Synthetic Superdisintegrant such as Crosspovidone and a 
Natural Superdisintegrant Fenugreek powder in different 
concentration. 32 factorial designs was applied   by using 
design expert software.  IR spectroscopic study indicates no 
drug-excipient interaction in the prepared formulations. The 
prepared Orodispersible tablets exhibited satisfactory 
physic-chemical characteristic. 32 full factorial design and 
optimization technique successfully used in the development 
of orodispersible tablets. The drug release of the best F9 
formulation was found to be 99.56% within 6 min.The tablet 
prepared using Crosspovidone and fenugreek powder F9 
were found to be best formulations that showed the 
dissolution rate in 6 minutes. This is a Novel combination of 
fenugreek gum with Crosspovidone. Comparing the all the 
fabricated formulations, batch F9 was considered as 
optimized formulation since it  shows excellent fast 
disintegration, in vitro dissolution, and faster drug release 
within 6 mins in comparison to other batches also stable in 
stability.  
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